Inventor · disambiguated record
Stephen Arneric
Also filed as: ARNERIC STEPHEN P
4 granted patents·14 pending applications·68 citations·filing 1991–2004
76Inventor score
Top patents by PatentIndex Score
18 records- 0181US5409946AIsoxazole, isothiazole and pyrazole compounds that enhance cognitive functionABBOTT LAB·Filed 1993·Granted Apr 25, 1995·50 cites·13 claims
- 0273US6403575B13-Pyridyl enantiomers and their use as analgesicsABBOTT LAB·Filed 2000·Granted Jun 11, 2002·3 cites·4 claims
- 0356US2004116533A1Pharmaceutical compositionFiled 2003·Application pending·0 cites
- 0452US2005085479A1Mediated central nervous system compositions of a cyclooxygenase-2 selective inhibitor and a corticotropin releasing factor antagonist for the treatment of ischemic disorders or injuryPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0552US2005070524A1Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0652US2005101629A1Compositions of a chromene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 0751US6133253A3-Pyridyl enantiomers and their use as analgesicsABBOTT LAB·Filed 1997·Granted Oct 17, 2000·12 cites·6 claims
- 0850US2004235925A1Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereofPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 0943US2003060513A1Pharmaceutical compositionFiled 2001·Application pending·0 cites
- 1043US2005159471A1Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1143US2004248925A1Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinenceFRAIL DONALD E·Filed 2003·Application pending·0 cites
- 1243US2005113433A1Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1343US2005026919A1Compositions of a cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1441US2004204411A1Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereofPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1539US2004248932A1Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinenceFiled 2003·Application pending·0 cites
- 1639US2004248933A1Use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinenceFiled 2003·Application pending·0 cites
- 1738US2005059654A1Method for treatment of depression and anxiety disorders by combination therapyFiled 2004·Application pending·0 cites
- 1831US5272155A(+)-2-methylpiperidine as modulator of cholinergic systemsABBOTT LAB·Filed 1991·Granted Dec 21, 1993·3 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Stephen Arneric files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →